Cadence Capital Management’s Medtronic MDT Stock Holding History

Cadence Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.88M	Sell	27,747 -7,253	-21%	-$728K	0.7%	27
2020 Q2	$3.21M	Buy	35,000 +4,640	+15%	+$445K	0.47%	33
2020 Q1	$2.74M	Buy	30,360 +12,356	+69%	+$1.31M	0.46%	51
2019 Q4	$2.04M	Sell	18,004 -1,123	-6%	-$123K	0.22%	129
2019 Q3	$2.08M	Sell	19,127 -5,947	-24%	-$620K	0.29%	129
2019 Q2	$2.44M	Buy	25,074 +8,793	+54%	+$803K	0.24%	123
2019 Q1	$1.48M	Buy	+16,281	New	+$1.46M	0.13%	218
2018 Q4	–	Sell	-85,739	Closed	-$8.43M	–	557
2018 Q3	$8.43M	Sell	85,739 -4,910	-5%	-$454K	0.46%	60
2018 Q2	$7.76M	Sell	90,649 -4,025	-4%	-$336K	0.46%	58
2018 Q1	$7.59M	Buy	94,674 +84	+0.1%	+$6.93K	0.49%	55
2017 Q4	$7.64M	Sell	94,590 -53,821	-36%	-$4.31M	0.49%	60
2017 Q3	$11.5M	Buy	+148,411	New	+$12.3M	0.72%	41
2016 Q2	–	Sell	-23,024	Closed	-$1.73M	–	629
2016 Q1	$1.73M	Sell	23,024 -755	-3%	-$56.9K	0.12%	195
2015 Q4	$1.83M	Sell	23,779 -1,655	-7%	-$125K	0.12%	197
2015 Q3	$1.7M	Sell	25,434 -2,099	-8%	-$155K	0.12%	199
2015 Q2	$2.04M	Sell	27,533 -290	-1%	-$22.2K	0.11%	230
2015 Q1	$2.17M	Buy	27,823 +1,965	+8%	+$149K	0.13%	208
2014 Q4	$1.87M	Sell	25,858 -28,992	-53%	-$2.01M	0.11%	243
2014 Q3	$3.4M	Sell	54,850 -9,165	-14%	-$583K	0.18%	154
2014 Q2	$4.08M	Sell	64,015 -23,740	-27%	-$1.44M	0.2%	205
2014 Q1	$5.4M	Sell	87,755 -31,000	-26%	-$1.81M	0.23%	177
2013 Q4	$6.82M	Sell	118,755 -18,845	-14%	-$1.07M	0.26%	118
2013 Q3	$7.33M	Sell	137,600 -23,400	-15%	-$1.26M	0.25%	180
2013 Q2	$8.29M	Buy	+161,000	New	+$7.96M	0.39%	125

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cadence Capital Management's MDT Position: Q3 2020 in Review

Cadence Capital Management reduced its Medtronic (MDT) stake by 21% in Q3 2020, selling an estimated $728K and leaving 27,747 shares worth $2.88M. The position accounts for 0.7% of the portfolio, ranked #27.

Cadence Capital Management first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $11.5M in Q3 2017. 1,810 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

Cadence Capital Management held 27,747 shares of Medtronic worth $2.88M as of Q3 2020.
Cadence Capital Management sold 7,253 Medtronic shares in Q3 2020, an estimated $728K.
Medtronic made up 0.7% of Cadence Capital Management's portfolio in Q3 2020, its #27 holding.
Cadence Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
Cadence Capital Management's Medtronic position peaked at $11.5M in Q3 2017.
1,810 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.